Antigen-Specific Immune Tolerance Europe Summit

Conference themes
The clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals, partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to unite.

Professional congress organizer (PCO)
Hanson Wade

Notes
Brochure: https://go.evvnt.com/264511-0?pid=4832

Speakers: Robert (Bob) Anderson (ImmusanT), Arpita Maiti (Pfizer), Keith Martin (Apitope), Tim Jessen (Topas Therapeutics), Lawrence Steinman (Tolerion), David Wraith (University of Birmingham)

https://go.evvnt.com/264511-1?pid=4832

Hanson Wade